ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

AFMD Affimed NV

4,88
-0,47 (-8,79%)
Após o horário de negociação
Última atualização: 17:31:00
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Affimed NV AFMD NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,47 -8,79% 4,88 17:31:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
5,36 4,865 5,435 4,88 5,35
mais cotações »

Notícias Recentes

Data Hora Fonte Título
24/04/202405:05GLOBEAffimed Announces Acceptance of AFM24 Clinical Abstract at..
28/03/202407:30GLOBEAffimed Reports 2023 Financial Results and Operational..
21/03/202407:30GLOBEAffimed To Report Full Year 2023 Financial Results &..
06/03/202408:30GLOBEAffimed Announces 1-for-10 Reverse Stock Split
08/01/202418:05GLOBEAffimed Provides Clinical Response Update on AFM24-102 Trial..
08/01/202410:00GLOBEAffimed Announces Leadership Change and Organizational..
03/01/202408:30GLOBEAffimed Announces Sale of Wholly-Owned Subsidiary AbCheck
11/12/202308:02GLOBEAffimed Announces Positive Data for AFM24 in Combination..
11/12/202308:00GLOBEAffimed Announces Updated Phase 1/2 Data from Acimtamig in..
04/12/202308:30GLOBEAffimed to Host Investor Conference Call Highlighting..
14/11/202308:30GLOBEAffimed Reports Third Quarter 2023 Financial Results and..
09/11/202308:30GLOBEAffimed Announces Acimtamig as International Nonproprietary..
07/11/202308:30GLOBEAffimed to Report Third Quarter 2023 Financial Results &..
03/11/202313:05GLOBEAffimed Presents Preclinical Data Showing that Addition of..
02/11/202310:05GLOBEAffimed Announces Oral Presentation of Phase 1/2 Data from..
01/11/202307:30GLOBEAffimed to Participate in Upcoming Investor Conferences
04/10/202307:30GLOBEAffimed Announces Listing Transfer to Nasdaq Capital Markets
27/09/202310:05GLOBEAffimed Announces Acceptance of an Abstract Comparing NK..
21/09/202307:30GLOBEAffimed to Present at the Cantor Global Healthcare..
12/09/202307:30GLOBEAffimed Receives FDA Fast Track Designation for AFM13 in..
07/09/202307:30GLOBEAffimed to Present at the H.C. Wainwright Annual Global..
22/08/202306:00GLOBEAffimed Announces Publication in the Journal mAbs on..
10/08/202307:30GLOBEAffimed Reports Second Quarter 2023 Financial Results and..
03/08/202307:30GLOBEAffimed to Report Second Quarter 2023 Financial Results..
31/07/202318:05GLOBEAffimed Announces an ASCO Breakthrough Poster Presentation..
22/06/202307:30GLOBEAffimed Announces Addition of Dr. Constanze Ulmer-Eilfort to..
09/06/202318:59GLOBEAffimed Announces Acceptance of Abstracts at the 17th..
03/06/202310:00GLOBEAffimed Presents AFM24 Monotherapy Data in Non-Small Cell..
30/05/202307:30GLOBEAffimed to Present at the 2023 Jefferies Healthcare..
25/05/202318:00GLOBEAffimed Announces Publication of AFM24 Clinical Abstracts..
23/05/202307:30GLOBEAffimed Reports First Quarter 2023 Financial Results and..
23/05/202307:15GLOBEAffimed Announces IND Clearance for a Phase 2 Clinical Trial..
22/05/202307:30GLOBEAffimed Announces Annual General Meeting of Shareholders
16/05/202307:30GLOBEAffimed to Report First Quarter 2023 Financial Results &..
11/05/202311:05GLOBEAffimed Announces Abstracts at the Annual Meeting of the..
26/04/202311:00GLOBEAffimed Announces AFM24 Clinical Abstracts Accepted for the..

Seu Histórico Recente

Delayed Upgrade Clock